MedTrace Logo

Emergency Treatment of Coral Snake Envenomation With Antivenom

NCT01337245 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2023-05-26

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see whether a new F(ab')2 antivenom will prevent injury and death from the bite of a coral snake.

Funding Source - FDA OOPD.

Conditions

  • Coral Snake Bite
  • Toxic Effect of Coral Snake Venom

Interventions

DRUG

Snake (Micrurus) North American immune F(ab')2 Equine

5 vials of study drug reconstituted and diluted to 250 mL Normal Saline and administered intravenously.

Sponsors & Collaborators

  • University of Arizona

    lead OTHER

Principal Investigators

  • Leslie Boyer, MD · VIPER Institute, University of Arizona

  • Jason W. Wilson, MD · Tampa General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2016-11-11
Completion
2016-11-11

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01337245 on ClinicalTrials.gov